Citation Impact
52 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine
2024 Standout
Works of Amy E. Armstrong being referenced
Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)
2018
Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells
2011
Author Peers
| Author | Neurology | PRM | Molecular Biology | Epidemiology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Amy E. Armstrong | 112 | 128 | 130 | 177 | 44 | 595 | |
| Gerhard Jonschker | 1 | 5 | 10 | 480 | |||
| Sandra Hughes‐Hassell | 28 | 467 | |||||
| Maurice Konings | 3 | 7 | 367 | 56 | 26 | 700 | |
| João Angelo Lima Perini | 2 | 22 | 8 | 30 | 664 | ||
| Thomas L.Greenbaum | 5 | 1 | 13 | 5 | 558 |
All Works
Login with ORCID to disown or claim papers
Loading papers...